CSSPF (NIOX Group) EPS without NRI: $0.02 (TTM As of Dec. 2025)


CSSPF NIOX Group PLC CSSPF
77 GF Score
Price $0.75
GF Value $1.21
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is NIOX Group EPS without NRI?

NIOX Group CSSPF 77 EPS without NRI is $0.02 as of Dec. 2025. GuruFocus rates CSSPF with a GF Score™ of 77/100 and a GF Value™ of $1.21 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 667 Medical Devices & Instruments companies, NIOX Group ranks worse than 82.61% on this metric.

NIOX Group's earnings per share without non-recurring items for the six months ended in Dec. 2025 was $0.00. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was $0.02.

During the past 12 months, NIOX Group's average earnings per share (NRI) Growth Rate was 100.00% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was -20.60% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for NIOX Group's EPS without NRI or its related term are showing as below:

CSSPF' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -60.3   Med: -20.6   Max: 32
Current: -20.6

During the past 13 years, NIOX Group's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 32.00% per year. The lowest was -60.30% per year. And the median was -20.60% per year.

CSSPF's 3-Year EPS without NRI Growth Rate is ranked worse than
82.61% of 667 companies
in the Medical Devices & Instruments industry
Industry Median: 8.2 vs CSSPF: -20.60

NIOX Group's EPS (Diluted) for the six months ended in Dec. 2025 was $0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.02.

NIOX Group's EPS (Basic) for the six months ended in Dec. 2025 was $0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.02.


NIOX Group  (OTCPK:CSSPF) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


NIOX Group EPS without NRI Related Terms


NIOX Group EPS without NRI Historical Data

* Premium members only.

The historical data trend for NIOX Group's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NIOX Group EPS without NRI Chart

NIOX Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.04 0.03 0.01 0.02

NIOX Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.01 -0.00 0.02 0.00

CSSPF vs ABT, SYK, MDT: EPS without NRI Comparison

For the Medical Devices subindustry, NIOX Group's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NIOX Group PE Ratio without NRI vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, NIOX Group's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where NIOX Group's PE Ratio without NRI falls into.


CSSPF
77GF Score
NIOX Group PLC CSSPF
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NIOX Group EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of $0.02 mean?
NIOX Group (CSSPF) has a EPS without NRI of $0.02 as of Dec. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on NIOX Group and its competitors. According to the industry distribution chart, NIOX Group ranks #551 out of 667 companies in the Medical Devices & Instruments industry, placing it in the top 82.6%.
Is NIOX Group's EPS without NRI too high?
NIOX Group's current EPS without NRI is $0.02. The Medical Devices & Instruments industry median EPS without NRI is 8.20. NIOX Group's value of $0.02 is 99.8% below this industry median. Based on the distribution chart, NIOX Group ranks #551 out of 667 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, NIOX Group has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does NIOX Group's EPS without NRI compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, NIOX Group ranks #551 out of 667 companies for EPS without NRI. This places NIOX Group in the lower half of its industry. The industry median EPS without NRI is 8.20. NIOX Group's value of $0.02 is 99.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Devices & Instruments company?
The median EPS without NRI among Medical Devices & Instruments companies is 8.20, based on 667 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NIOX Group's current EPS without NRI of $0.02 is 99.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on NIOX Group and its competitors. For the Medical Devices & Instruments industry, the median EPS without NRI is 8.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NIOX Group's current EPS without NRI is $0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NIOX Group stock overvalued right now?
Based on GuruFocus' analysis, NIOX Group (CSSPF) is currently considered Significantly Undervalued. The stock's GF Value™ is $1.21, compared to a current price of $0.75 — trading 38% below its estimated fair value. The current EPS without NRI is $0.02 and 99.8% below the Medical Devices & Instruments industry median of 8.20. NIOX Group's overall GF Score™ is 77/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For NIOX Group (CSSPF), the current EPS without NRI is $0.02 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is NIOX Group (CSSPF) Overvalued in 2026?

Based on GuruFocus' analysis, NIOX Group stock appears to be undervalued. The current stock price of $0.75 is trading 38% below its estimated GF Value™ of $1.21. GuruFocus considers NIOX Group to be Significantly Undervalued.

Key valuation signals for CSSPF:

  • EPS without NRI: $0.02
  • GF Value™: $1.21 vs. price of $0.75 (38% below fair value)
  • GF Score™: 77/100 with 1 warning sign
  • Industry Position: 99.8% below the Medical Devices & Instruments median (#551 of 667)

No single metric tells the full story. See the CSSPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


NIOX Group Business Description

Other Exchanges NIOXl:UKNIOX:UK82C:Germany
Address 1 Robert Robinson Avenue, Magdalen Centre, The Oxford Science Park, Oxford, GBR, OX4 4GA
NIOX Group PLC is engaged in improving the diagnosis, monitoring and management of both asthma and COPD by providing greater patient access to FeNO testing. The company is engaged in the design, development, and commercialization of medical devices for the measurement of FeNO, a precise biomarker for type 2 inflammation which is present in asthma and COPD. Its device, NIOX VERO, is increasingly recognised by healthcare professionals as an important tool to improve the diagnosis, monitoring and management of asthma and COPD. It operates in single segment of NIOX relates to the portfolio of products used to improve asthma diagnosis, monitoring and management by measuring fractional exhaled nitric oxide (FeNO).
77GF Score

Get the complete analysis for CSSPF

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.75
Price
$1.21
GF Value